vs
Side-by-side financial comparison of Azenta, Inc. (AZTA) and ESCO TECHNOLOGIES INC (ESE). Click either name above to swap in a different company.
ESCO TECHNOLOGIES INC is the larger business by last-quarter revenue ($289.7M vs $148.6M, roughly 1.9× Azenta, Inc.). ESCO TECHNOLOGIES INC runs the higher net margin — 9.9% vs -10.4%, a 20.3% gap on every dollar of revenue. On growth, ESCO TECHNOLOGIES INC posted the faster year-over-year revenue change (17.3% vs 0.8%). ESCO TECHNOLOGIES INC produced more free cash flow last quarter ($63.0M vs $14.7M). Over the past eight quarters, ESCO TECHNOLOGIES INC's revenue compounded faster (7.8% CAGR vs 4.4%).
Azenta, was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics.
Esco is a Singaporean brand that develops, manufactures, and sells products and services for laboratories.
AZTA vs ESE — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $148.6M | $289.7M |
| Net Profit | $-15.4M | $28.7M |
| Gross Margin | 42.9% | 41.4% |
| Operating Margin | -4.9% | 13.2% |
| Net Margin | -10.4% | 9.9% |
| Revenue YoY | 0.8% | 17.3% |
| Net Profit YoY | -15.7% | 22.2% |
| EPS (diluted) | $-0.34 | $1.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.6M | $289.7M | ||
| Q3 25 | $159.2M | $286.5M | ||
| Q2 25 | $143.9M | $296.3M | ||
| Q1 25 | $143.3M | $265.5M | ||
| Q4 24 | $147.4M | $247.0M | ||
| Q3 24 | $150.6M | $298.5M | ||
| Q2 24 | $144.3M | $260.8M | ||
| Q1 24 | $136.4M | $249.1M |
| Q4 25 | $-15.4M | $28.7M | ||
| Q3 25 | $50.9M | $218.7M | ||
| Q2 25 | $-48.0M | $26.1M | ||
| Q1 25 | $-47.7M | $31.0M | ||
| Q4 24 | $-11.0M | $23.5M | ||
| Q3 24 | $-6.6M | $34.3M | ||
| Q2 24 | $-6.6M | $29.2M | ||
| Q1 24 | $-137.4M | $23.2M |
| Q4 25 | 42.9% | 41.4% | ||
| Q3 25 | 45.4% | 45.9% | ||
| Q2 25 | 46.2% | 41.2% | ||
| Q1 25 | 43.8% | 41.1% | ||
| Q4 24 | 46.7% | 39.8% | ||
| Q3 24 | 45.5% | 40.1% | ||
| Q2 24 | 44.8% | 39.6% | ||
| Q1 24 | 43.8% | 38.8% |
| Q4 25 | -4.9% | 13.2% | ||
| Q3 25 | 1.2% | 17.2% | ||
| Q2 25 | -1.3% | 11.2% | ||
| Q1 25 | -12.7% | 15.3% | ||
| Q4 24 | -5.9% | 11.4% | ||
| Q3 24 | -3.1% | 14.8% | ||
| Q2 24 | -4.9% | 14.3% | ||
| Q1 24 | -18.1% | 11.7% |
| Q4 25 | -10.4% | 9.9% | ||
| Q3 25 | 32.0% | 76.3% | ||
| Q2 25 | -33.4% | 8.8% | ||
| Q1 25 | -33.3% | 11.7% | ||
| Q4 24 | -7.5% | 9.5% | ||
| Q3 24 | -4.4% | 11.5% | ||
| Q2 24 | -4.5% | 11.2% | ||
| Q1 24 | -100.8% | 9.3% |
| Q4 25 | $-0.34 | $1.11 | ||
| Q3 25 | $1.12 | $8.43 | ||
| Q2 25 | $-1.05 | $1.01 | ||
| Q1 25 | $-1.04 | $1.20 | ||
| Q4 24 | $-0.25 | $0.91 | ||
| Q3 24 | $-0.25 | $1.32 | ||
| Q2 24 | $-0.12 | $1.13 | ||
| Q1 24 | $-2.48 | $0.90 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $336.6M | $103.8M |
| Total DebtLower is stronger | — | $145.5M |
| Stockholders' EquityBook value | $1.7B | $1.6B |
| Total Assets | $2.1B | $2.4B |
| Debt / EquityLower = less leverage | — | 0.09× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $336.6M | $103.8M | ||
| Q3 25 | $279.8M | $101.3M | ||
| Q2 25 | $270.0M | $78.7M | ||
| Q1 25 | $253.6M | $57.4M | ||
| Q4 24 | $377.5M | $71.3M | ||
| Q3 24 | $280.0M | $66.0M | ||
| Q2 24 | $336.5M | $63.0M | ||
| Q1 24 | $353.5M | $59.4M |
| Q4 25 | — | $145.5M | ||
| Q3 25 | — | $186.0M | ||
| Q2 25 | — | $525.0M | ||
| Q1 25 | — | $88.0M | ||
| Q4 24 | — | $112.0M | ||
| Q3 24 | — | $122.0M | ||
| Q2 24 | — | $173.0M | ||
| Q1 24 | — | $191.0M |
| Q4 25 | $1.7B | $1.6B | ||
| Q3 25 | $1.7B | $1.5B | ||
| Q2 25 | $1.7B | $1.3B | ||
| Q1 25 | $1.7B | $1.3B | ||
| Q4 24 | $1.7B | $1.2B | ||
| Q3 24 | $1.8B | $1.2B | ||
| Q2 24 | $2.0B | $1.2B | ||
| Q1 24 | $2.2B | $1.2B |
| Q4 25 | $2.1B | $2.4B | ||
| Q3 25 | $2.1B | $2.4B | ||
| Q2 25 | $2.0B | $2.5B | ||
| Q1 25 | $2.0B | $1.8B | ||
| Q4 24 | $2.0B | $1.8B | ||
| Q3 24 | $2.1B | $1.8B | ||
| Q2 24 | $2.3B | $1.8B | ||
| Q1 24 | $2.6B | $1.8B |
| Q4 25 | — | 0.09× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.09× | ||
| Q3 24 | — | 0.10× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.8M | $68.9M |
| Free Cash FlowOCF − Capex | $14.7M | $63.0M |
| FCF MarginFCF / Revenue | 9.9% | 21.7% |
| Capex IntensityCapex / Revenue | 4.2% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 2.40× |
| TTM Free Cash FlowTrailing 4 quarters | $30.9M | $239.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.8M | $68.9M | ||
| Q3 25 | $2.2M | $109.9M | ||
| Q2 25 | $25.8M | $73.7M | ||
| Q1 25 | $14.4M | $24.1M | ||
| Q4 24 | $29.8M | $34.2M | ||
| Q3 24 | $17.7M | $72.1M | ||
| Q2 24 | $9.8M | $36.2M | ||
| Q1 24 | $8.7M | $10.5M |
| Q4 25 | $14.7M | $63.0M | ||
| Q3 25 | $-5.7M | $97.8M | ||
| Q2 25 | $15.0M | $64.9M | ||
| Q1 25 | $7.0M | $14.0M | ||
| Q4 24 | $22.0M | $29.0M | ||
| Q3 24 | $8.3M | $60.9M | ||
| Q2 24 | $1.3M | $27.6M | ||
| Q1 24 | $428.0K | $2.0M |
| Q4 25 | 9.9% | 21.7% | ||
| Q3 25 | -3.6% | 34.1% | ||
| Q2 25 | 10.4% | 21.9% | ||
| Q1 25 | 4.9% | 5.3% | ||
| Q4 24 | 15.0% | 11.7% | ||
| Q3 24 | 5.5% | 20.4% | ||
| Q2 24 | 0.9% | 10.6% | ||
| Q1 24 | 0.3% | 0.8% |
| Q4 25 | 4.2% | 2.0% | ||
| Q3 25 | 4.9% | 4.2% | ||
| Q2 25 | 7.5% | 3.0% | ||
| Q1 25 | 5.2% | 3.8% | ||
| Q4 24 | 5.3% | 2.1% | ||
| Q3 24 | 6.2% | 3.8% | ||
| Q2 24 | 5.9% | 3.3% | ||
| Q1 24 | 6.1% | 3.4% |
| Q4 25 | — | 2.40× | ||
| Q3 25 | 0.04× | 0.50× | ||
| Q2 25 | — | 2.83× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 1.46× | ||
| Q3 24 | — | 2.10× | ||
| Q2 24 | — | 1.24× | ||
| Q1 24 | — | 0.45× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AZTA
| Multiomics | $67.2M | 45% |
| Core Products | $47.6M | 32% |
| Sample Repository Solutions | $33.8M | 23% |
ESE
| US Government | $98.0M | 34% |
| Utility Solutions Group | $87.5M | 30% |
| RF Shielding And Test | $58.3M | 20% |
| Commercial | $45.8M | 16% |
| Related Party | $1.3M | 0% |
